Infigratinib-Boc
Infigratinib-Boc is a derivative of Infigratinib containing a Boc (t-Butyloxy carbonyl) group. Infigratinib is an ATP-competitive pan-FGFR inhibitor[1].
Product Specifications
CAS Number
2504949-83-9
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/infigratinib-boc.html
Purity
98.29
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=C(Cl)C(OC)=CC(OC)=C1Cl)N(C)C2=CC(NC(C=C3)=CC=C3N4CCN(C(OC(C)(C)C)=O)CC4)=NC=N2
Molecular Formula
C29H35Cl2N7O5
Molecular Weight
632.54
References & Citations
[1]Guangyan Du, et al. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. Angew Chem Int Ed Engl. 2021 Jul 12;60 (29) :15905-15911.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-13294R-Cy7 100 µL
Phospho-GATA3 (Ser308) Polyclonal Antibody, Cy7 Conjugated
Sign In for Pricing
View Details 
MBS2012043-01 0.01 mg
Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)
Sign In for Pricing
View Details MBS2012043-02 0.05 mg
Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)
Sign In for Pricing
View Details MBS2012043-03 0.1 mg
Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)
Sign In for Pricing
View Details MBS2012043-04 0.2 mg
Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)
Sign In for Pricing
View Details MBS2012043-05 0.5 mg
Recombinant Leucine Rich Repeat Kinase 2 (LRRK2)
Sign In for Pricing
View Details